The majority of patients showing neuronal migration disorders in cortical structures suffer from pharmacoresistant epilepsy. In order to study the molecular and cellular mechanisms underlying this pronounced hyperexcitability, we used an animal model of focal cortical dysplasia demonstrating structural malformations which resemble the human pathology of microgyria. Neocortical slices prepared from adult rats, which at the day of birth received a cortical freeze lesion, were analysed in vitro with an array of eight extracellular recording electrodes to investigate the pattern and pharmacology of propagating epileptiform activity in microgyric cortex. In cortical slices exhibiting neuronal migration disorders, orthodromic synaptic stimulation elicited late recurrent activity and early epileptiform responses that spread with 0.06 m/s over ജ 3.5 mm across the cortex. Application of a N-methyl-D-aspartate (NMDA) antagonist blocked the late recurrent activity, but not the propagation of the early epileptiform responses. The latter were blocked by an (Ϯ)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) antagonist, indicating that the spread of this activity was predominantly mediated by activation of AMPA receptors. A very similar response pattern could be observed in neocortical slices obtained from untreated age-matched control rats, when the slice was partially disinhibited by bath-application of 5 µM bicuculline methiodide. Stimulus-evoked epileptiform signals recorded in disinhibited slices propagated with 0.08 m/s across the cortex and showed the same sensitivity to ionotropic glutamate antagonists as in dysplastic cortex. Our results indicate that widespread structural and/or functional modifications of the AMPA receptor and possibly also of the γ-amino-butyric acid type A receptor contribute to the pronounced hyperexcitability in dysplastic cortex.
Introduction
Neuronal migration disorders (NMDs) are structural malformations in the cerebellum, hippocampus and neocortex, which result from early developmental disturbances or genetic defects (Aicardi, 1994; Reiner et al., 1995; Eksioglu et al., 1996; Kuzniecky & Barkovich, 1996) . In cortical structures, NMDs are generally associated with medically refractory epilepsy (Palmini et al., 1991b; Jay & Becker, 1994; Guerrini et al., 1997 ) and a significant therapeutical success can be only obtained after surgical removal of the structural abnormality (Palmini et al., 1991a) . With the improvement of modern imaging techniques it recently became clear that NMDs are much more common than previously estimated (Brodtkorb et al., 1992; Kuzniecky, 1994; Lee et al., 1994) and that a large population of patients suffering from pharmaco-resistant epilepsy show obvious cortical NMDs (Barkovich & Kjos, 1992; Kuzniecky et al., 1993) . Immunocytochemical studies on cortical specimen from patients with intractable epilepsy revealed a significant loss of parvalbumin, calbindin D-28 k and somatostatin immunoreactive cells and fibres, indicating that presumably inhibitory local-circuit neurons are diminished in human dysplastic cortex (Ferrer et al., 1992 (Ferrer et al., , 1994 . This loss of inhibitory elements may result in a decrease of γ-aminobutyric acid (GABA)-mediated inhibition and a subsequent enhanced excitability, as recently demonstrated with in vitro recording techniques in neocortical slices obtained from patients with NMDs and pharmacoresistant epilepsy (Mattia et al., 1995) . However, despite these various experimental and clinical data, very little is known about the cellular mechanisms underlying the pronounced hyperexcitability of dysplastic cortex and the possible molecular, morphological and cellular physiological modifications. To address these issues in detail, different animals models of cortical NMDs have been developed. Pre-or neonatal irradiation (Ito, 1995; Roper et al., 1995) , application of methylazoxymethanol (for review see Cattabeni & Di Luca, 1997) , ibotenate (Innocenti & Berbel, 1991; Marret et al., 1995) , neurotrophin (Brunstrom et al., 1997) , cocaine (Gressens et al., 1992a) and ethanol (Gressens et al., 1992b) , as well as a focal freeze lesion (Dvorak & Feit, 1977; Dvorak et al., 1978) or other mechanical manipulations (Ferrer et al., 1993) to the cortex of newborn mammals produce severe NMDs. In the rat freeze lesion model, the adult cerebral cortex shows under in vitro conditions a pronounced hyperexcitability and epileptiform activity (Jacobs et al., 1996; Luhmann & Raabe, 1996) , indicating that this model replicates not only the structural abnormalit- ies, but also some of the functional disorders described in human dysplastic cortex. We therefore used this model to analyse the extent of functional and structural cellular modifications in the rat dysplastic cortex by performing multiple simultaneous extracellular recordings in large cortical segments and by quantitatively measuring the density of excitatory and inhibitory receptors in whole brain sections . The functional role of ionotropic glutamate receptors was evaluated in rat dysplastic cortex and compared to the pharmacology of epileptiform activity recorded in disinhibited cortical slices from normal rats. The combination of these in vitro electrophysiological and quantitative receptor autoradiographical analyses allowed the conclusion, that the expression of epileptiform activity in dysplastic cortex can be attributed to wide-spread changes in the density of GABA and AMPA receptors. These global modifications may substantially contribute to the resistance of NMD-associated epilepsy to conventional therapy.
Materials and methods

Freeze lesion model
We used a modification of the cortical freeze lesion model in rats as initially described by Dvorak & Feit (1977) (for details see Luhmann & Raabe, 1996) . In brief, Wistar rats younger than 24 h (n ϭ 15) were anaesthetized by hypothermia and a liquid nitrogen cooled copper cylinder of 1 mm diameter was placed on the calvarium above the frontoparietal cortex for 8 s. Two other identical lesions were induced in rostro-caudal direction. This protocol resulted in structural malformations in frontal and parietal cortical areas. Sham-operated rats (n ϭ 6) were treated in the same way with the exception that the temperature of the copper cylinder was 21-23°C. Freeze-lesioned and sham-operated rats survived for 1-4 months before they were used for in vitro electrophysiological analyses. A second control group consisted of nine age-matched untreated animals.
In vitro slice preparation and recording techniques
Rats were deeply anaesthetized with ether, decapitated and a tissue block including the frontoparietal cortex was rapidly removed and stored for 1-2 min in ice-cold artificial cerebrospinal fluid (ACSF) consisting of (in mM): NaCl, 124; KCl, 3; NaH 2 PO 4 , 1.25; MgSO 4 , 1.8; CaCl 2 , 1.6; NaHCO 3 , 26; and glucose, 10 (pH of 7.4 when saturated with 95% O 2 -5% CO 2 ). Coronal slices of 400 µm thickness were cut with a Campden vibratome, trimmed to smaller pieces and transferred to the interface-type recording chamber (34-35°C) or to an incubation-storage chamber (32-33°C). Slices were allowed to recover for at least 1 h before recording began. Extracellular recordings were performed with eight tungsten 4-5 MΩ microelectrodes (FHC, Bowdoinham, ME, USA) positioned in medio-lateral axis in the upper 600 µm from the cortical surface. The first electrode was positioned close to the microgyric cortex and the remaining electrodes were placed in lateral direction with 0.5 mm tip separation (Fig. 1) . The stimulating electrode consisted of two sharpened tungsten wires which were separated by 150-200 µm (stim in Fig. 1 ). In freeze-lesioned animals, the stimulating electrode was either positioned below recording electrode number 1 close to the white matter or µ 3.5 mm lateral from the pseudosulcus below recording electrode number 8. Similar electrode positions were used in cortical slices obtained from shamoperated and untreated animals. Orthodromic synaptic responses were elicited by electrical stimulation with 200-µs pulses at a frequency of ഛ 0.1 Hz. The stimulus intensity was gradually increased in 5-10 steps in a stimulus range from 2 to 30 V. Propagating epileptiform responses could be reliably evoked with stimulus intensities ranging from 40 to 100% of the intensity to elicit a maximal initial field potential response. Signals were recorded, stored and analysed with an 8-channel PC-based software program (TIDA, Heka elektronik, Lambrecht, Germany). The N-methyl-D-aspartate (NMDA) antagonist DL-2-amino-5-phosphonovaleric acid (APV, Sigma; 30 µM), the AMPA antagonist 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione (NBQX, Novo Nordisk, Måløv, Denmark; 10 µM) and the GABA A antagonist bicuculline methiodide (BMI, Sigma, Deisenhofen, Germany; 5 µM) was bath applied and washed in for at least 30 min before subsequent recording. Values throughout this report are given as mean Ϯ SEM. For statistical analyses, a Student's t-test was performed.
Results
Anatomy and behaviour
The local freeze lesions in neonatal rat cerebral cortex produced focal NMDs consisting of two-, three-or four-layered cortices (triangles in Fig. 2A-E) , ectopic cell clusters in layer I (open arrow in Fig. 2F ) and were accompanied by a complete loss of normal cortical architecture. These malformations were microscopically clearly visible in living slices and allowed the evaluation of the extent of obvious structural abnormalities. More detailed analyses of the Nissl-stained material revealed no obvious morphological changes in cortical regions located more than 1.5 mm from the centre of the malformation. No abnormal behaviour or epileptic syndromes could be observed in the freeze-lesioned animals. Preliminary EEG recordings from freely moving rats with NMDs demonstrated no irregularities in the EEG.
Propagation of epileptiform activity in dysplastic cortex
For functional analysis, the eight extracellular recording electrodes were positioned lateral to the microgyric cortex in the upper 600 µm (Fig. 1) . Extracellular recordings were performed on 81 slices prepared from 15 rats with NMDs, 21 slices from six sham-operated animals and 21 slices from nine untreated age-matched control rats. In neocortical slices prepared from rats with NMDs, electrical stimulation of the white matter/layer VI near the dysplastic cortex elicited at recording electrode position 1 an initial field potential response, which propagated across the cortex in lateral direction with a velocity of µ 0.06 m/s (n ϭ 73, Fig. 3A ). In addition, recurrent activity occurring with a latency of about 100 ms poststimulus also spread across the cortex. This pattern of propagating epileptiform activity could be observed in 59 of the 73 slices with cortical NMDs. In the remaining 14 slices, stimulus-evoked responses only spread over distances of ഛ 1 mm. The amplitude of the propagating response declined significantly (P Ͻ Ͻ 0.001) from 2.61 Ϯ 0.16 mV (n ϭ 73) at electrode 1 to 0.66 Ϯ 0.1 mV (n ϭ 15) at electrode 8, which was positioned 3.5 mm lateral from electrode 1 (Fig. 4C) . In eight slices from rats with NMDs, the stimulating electrode was positioned below recording electrode 8 µ 3.5 mm lateral to the pseudosulcus (Fig. 5) . This stimulus protocol elicited at electrode 8 an average field potential response of 1.92 Ϯ 0.23 mV, which propagated over a maximal distance of 1.5 mm to electrode 5 where an average response of 0.13 Ϯ 0.07 mV could be measured (Fig. 4D) .
In contrast to cortices with NMDs, orthodromic synaptic stimulation of the white matter/layer VI in cortical slices from age-matched untreated or sham-operated rats revealed a spatially much more restricted response pattern (compare Fig. 6A with Fig. 3A) . In these controls, a clear field potential response could be only observed at the next neighbouring electrode located 0.5 mm lateral (Fig. 4A,B) . The average field potential response amplitude measured at electrode 1 in untreated controls and sham-operated animals amounted to 2.44 Ϯ 0.28 mV (n ϭ 21) and 2.2 Ϯ 0.21 mV (n ϭ 21), respectively, and was not significantly different when compared to the results obtained in dysplastic cortex (Fig. 4) . However, already 0.5 mm lateral to the stimulated column at recording electrode position 2, the response amplitude in NMD cortex (1.6 Ϯ 0.1 mV, n ϭ 71) was significantly larger as compared with the untreated controls © 1998 European Neuroscience Association, European Journal of Neuroscience, 10, 3085-3094 (0.94 Ϯ 0.18, n ϭ 21, P Ͻ 0.01) and the sham-operated animals (0.47 Ϯ 0.11 mV, n ϭ 21, P Ͻ 0.001) (Fig. 4) . This difference in the amplitude of synaptic activity between controls and cortices with NMDs was even more pronounced at distances ജ 1 mm lateral to the stimulating site (Fig. 4) , indicating that only in dysplastic cortex stimulus-evoked activity propagated over several millimetres in medio-lateral direction. Furthermore, this propagating activity could be only elicited by stimulating the tissue surrounding the microgyrus and not by activating remote areas (see Fig. 4D ).
Role of NMDA and AMPA receptors in propagating activity
The involvement of NMDA and AMPA receptors in the spread of stimulus-evoked epileptiform activity was analysed by adding the selective antagonist APV (30 µM) and NBQX (10 µM), respectively, to the bathing solution. In dysplastic cortices, application of APV blocked the expression of recurrent epileptiform activity, but did not significantly influence the spread or amplitude of the initial response ( Fig. 3B and hatched columns in Fig. 7A ; P ϾϾ 0.05 at all eight recording sites). Combined blockade of the NMDA and AMPA receptor by addition of NBQX to the APV-containing solution suppressed all epileptiform responses by blocking orthodromic excitatory synaptic activity ( Fig. 3C and filled columns in Fig. 7A , P ϽϽ 0.001 at all recording sites). In APV-and NBQX-containing bathing solutions occasionally only antidromic responses at recording electrode 1 and 2 could be observed (see upper trace in Fig. 3C ). The role of AMPA receptors in the generation and propagation of epileptiform activity was investigated in more detail by directly applying NBQX to the bathing solution. Under these conditions, all orthodromic synaptic activity was blocked, leaving only small responses due to antidromic activation (Fig. 7B) . These data indicate that AMPA, rather than NMDA receptors play a dominant role in the propagation of epileptiform activity in dysplastic cortex. However, NMDA receptors seem to be involved in the generation of late recurrent activity, since these signals were APV-sensitive (see Fig. 3B ).
Comparison to pattern in disinhibited neocortical slices from control animals
In order to address the question whether a similar pattern of propagating epileptiform activity can be induced in untreated control cortices by reducing the efficacy of intracortical inhibitory mechanisms, we bath-applied the selective GABA A receptor antagonist BMI in a concentration of 5 µM. This partial disinhibition resulted in the expression of severe epileptiform responses, which resembled in their propagation and pharmacology the pattern observed in dysplastic cortex (Fig. 6B) . In BMI-treated slices from control animals, orthodromic synaptic responses at the stimulated site increased to 183.1 Ϯ 69.9% in amplitude (hatched columns in Fig. 8A, n ϭ 11 ). This response spread with an average velocity of 0.08 m/s to all neighbouring recording sites and amounted to 44.5 Ϯ 14.6% (n ϭ11) in amplitude at electrode position 8 when compared to the control response recorded at position 1 (hatched columns in Fig. 8A ). In agreement with our observations in cortices with NMDs, addition of APV did not significantly influence the spread of BMI-induced synaptic responses, indicating that NMDA receptors do not contribute to the propagation of epileptiform activity in this model (Fig. 6C and cross-hatched columns in Fig. 8A ). In further correspondence with our results from dysplastic cortices, additional application of NBQX blocked all orthodromic synaptic activity ( Fig. 6D and filled columns in Fig. 8A ). The critical role of AMPA receptors in the spread of BMI-induced epileptiform activity was confirmed by the result, that all epileptiform signals could be blocked by NBQX application alone ( Fig. 9 and filled columns in Fig. 8B ). These results indicate that the pattern and pharmacology of epileptiform activity in dysplastic cortex corresponds in many aspects to the pattern observed in partially disinhibited cortex obtained from normal animals. 
Discussion
Our in vitro extracellular recordings in normal and dysplastic rat cortex gave the following results: (i) epileptiform synaptic activity originating from the aberrant cortex spreads with an average velocity of 0.06 m/s over ജ 3.5 mm in horizontal direction to neighbouring cortical regions; (ii) stimulation of remote cortical regions does not elicit a propagating epileptiform response; (iii) NMDA receptors are involved in the generation of late recurrent activity, but not in the wide-spread propagation of pathophysiological responses; (iv) activation of distant AMPA receptors represents a prerequisite for the spread of epileptiform activity; (v) a very similar pathophysiological pattern can be provoked in normal cortex, when the efficacy of intracortical GABAergic inhibition is reduced by pharmacological manipulation. These results are in good agreement with previous functional studies on human and rat dysplastic cortex. In infants and children (Fusco et al., 1992; Chugani et al., 1993) and adult patients (Taylor et al., 1971; Palmini et al., 1991b) suffering from intractable epilepsy, neuropathological analyses of the resected specimens revealed a wide spectrum of NMDs in different cortical areas. Since the large majority of these patients undergoing neurosurgery were seizure-free or achieved 75-90% seizure control in follow-ups ranging from 4 months to 15 years (Palmini et al., 1991a; Chugani et al., 1993) , it can be assumed that the severity of seizure activity strongly correlates with the expression of NMDs in the affected cortical regions. In addition, Palmini et al. (1991a) observed a correlation between the surgical outcome and the amount of tissue with malformations removed. Therefore these authors concluded that 'removal of the structural abnormality takes precedence over removal of epileptogenic tissue as the main surgical strategy to achieve seizure control' (Palmini et al., 1991a) .
These clinical data on the relationship between pharmaco-resistant epilepsy and NMDs are supported by experimental in vivo and in vitro studies. Exposure of foetal rats to external γ-irradiation produces NMDs in the telencephalon and electrographic seizure activity in the adults, but only in the presence of certain sedating agents (Roper et al., 1995) , indicating that NMDs are associated with an increased seizure susceptibility. Using a very similar freeze lesion model for the induction of focal NMDs in rat cerebral cortex as in the present study, Jacobs et al. (1996) observed in neocortical slices with structural malformations stimulus-evoked epileptiform activity spreading over the cortex in medio-lateral direction. In the majority of the slices, these responses could be only elicited upon stimulation of the tissue surrounding the microsulcus, but not by activation of the cortex located more than 2 mm from the malformation. These findings are in good agreement with our observations. Furthermore, Jacobs et al. (1996) also blocked the late recurrent epileptiform signals in dysplastic cortex by the NMDA antagonist APV, leaving the early response unaffected. Our previous (Luhmann & Raabe, 1996) and present experiments indicate that this early APV-insensitive component spreads uniformly over several millimetres to remote cortical areas. This early propagating response is strongly dependent on activation of AMPA receptors, since it can be completely blocked by the selective antagonist NBQX. Our observations further suggest that NMDA receptors are involved in late epileptiform responses, which may be generated within a local network surrounding the malformation. Intracellular recordings in this region demonstrated strong NMDA-receptor mediated excitatory postsynaptic potentials (EPSPs) with unusual voltage-dependence . Application of APV blocked this late component, but not the initial NBQXsensitive presumably propagating EPSP. These intracellular observations and our present extracellular recordings indicate that the spread of epileptiform activity across several millimetres seems to be predominantly mediated by activation of AMPA receptors. In the accompanying paper by Zilles et al. (1998) we demonstrate with quantitative receptor autoradiographical data that this result may be explained with a global up-regulation of AMPA receptors in the cortical regions surrounding the malformation.
A very similar propagation pattern with analogous pharmacology could be observed in neocortical slices obtained from untreated control rats, when intracortical GABAergic inhibition was suppressed by the GABA A receptor antagonist bicuculline methiodide. Under these conditions, stimulus-evoked epileptiform responses spread with 0.08 m/s (vs. 0.06 m/s in dysplastic cortex) across the cortical slice in medio-lateral direction. As in dysplastic cortex, the propagation of this activity was not influenced by NMDA antagonists, but blocked by NBQX, indicating that AMPA receptors play an important role in the transmission of pathophysiological discharge into neighbouring cortical regions. This result is in good agreement with previous in vivo observations in the primary motor cortex of adult rats (CastroAlamancos & Borrell, 1995) . Application of a GABA A antagonist through a microdialysis probe induced paroxysmal field potentials that were blocked by an AMPA antagonist, but not by APV, indicating that under these conditions the spread of pathophysiological activity is predominantly mediated by non-NMDA receptors (Castro-Alamancos & Borrell, 1995) . This report and our own observations in disinhibited neocortical slices (see also Alefeld et al., 1998) suggest that a GABA A receptor dysfunction may also contribute to the pronounced hyperexcitability in cortex with NMDs. This hypothesis is supported by our intracellular recordings in rat dysplastic cortex, which demonstrated only weak polysynaptic inhibitory postsynaptic potentials (IPSPs) with smaller peak conductances when compared to IPSPs recorded in sham-operated cortex . This disinhibition may result from a loss of inhibitory local circuit neurons as reported in human dysplastic cortex (Ferrer et al., 1992 (Ferrer et al., , 1994 , an impairment in GABA receptor function (Mileson et al., 1992; Li et al., 1993) , modifications in chloride driving force, changes in the GABA receptor subunit composition, a dephosphorylation of the GABA A receptor (Stelzer et al., 1988; Chen et al., 1990) , a disconnection of inhibitory interneurons from their excitatory input (Khazipov et al., 1993) or a loss of GABA receptors. Strong support for the latter hypothesis comes from our autoradiographical data on the quantitative distribution and density of GABA receptors , which demonstrated a pronounced decrease of GABA A and GABA B receptors at the lesioned site and in remote cortical areas. Our intracellular analyses of stimulus-evoked monosynaptic IPSPs in the presence of ionotropic glutamate receptor blockers demonstrated that GABAergic inhibition in microgyric and shamoperated cortex shows a similar efficacy, suggesting that inhibitory interneurons located in the border region of the malformation are deprived of their excitatory input . With intact glutamatergic synaptic transmission, this partial disconnection of the GABAergic system may promote the generation and propagation of epileptiform activity in the dysplastic cortex. 
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